G-d Sometimes you can talk absolute rubbish @col69 . And this is...

G-d

Sometimes you can talk absolute rubbish @col69 . And this is one of those times

I have watched the webinar for the second time and it only reinforces my opinion that this joint venture is a great opportunity for Starpharma

No cost to us, and 22.5% in a company once exited will give us a great pay day if successful. Nothing wrong with that

We will receive some revenue for preclinical work (pays the wages for biochemists), and after this as well. Medicxi has a fantastic network which it will rely on for the human clinical trials

Again it is another path Starpharma have gone down to broaden shareholder value

Point and play (different channel)

And we can do this multiple times


Would like to say however, only from the time of beginning of human trials will the 3-4 year period began. I stand corrected.

Look forward to many more positive announcements this month and the upcoming webinar in early May